Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 12700698)

1.

A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response.

Schweitzer JB, Lee DO, Hanford RB, Tagamets MA, Hoffman JM, Grafton ST, Kilts CD.

Neuropsychopharmacology. 2003 May;28(5):967-73. Epub 2003 Mar 26.

2.
3.

Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder.

Langleben DD, Acton PD, Austin G, Elman I, Krikorian G, Monterosso JR, Portnoy O, Ridlehuber HW, Strauss HW.

J Nucl Med. 2002 Dec;43(12):1624-9.

4.
5.

Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity.

Schweitzer JB, Lee DO, Hanford RB, Zink CF, Ely TD, Tagamets MA, Hoffman JM, Grafton ST, Kilts CD.

Biol Psychiatry. 2004 Oct 15;56(8):597-606.

PMID:
15476690
6.

Regional cerebral blood flow in children with attention deficit hyperactivity disorder: comparison before and after methylphenidate treatment.

Lee JS, Kim BN, Kang E, Lee DS, Kim YK, Chung JK, Lee MC, Cho SC.

Hum Brain Mapp. 2005 Mar;24(3):157-64.

PMID:
15486990
7.

The rCBF brain mapping in adolescent ADHD comorbid developmental coordination disorder and its changes after MPH challenging.

Yeh CB, Huang WS, Lo MC, Chang CJ, Ma KH, Shyu JF.

Eur J Paediatr Neurol. 2012 Nov;16(6):613-8. doi: 10.1016/j.ejpn.2012.02.007. Epub 2012 Mar 13.

PMID:
22417719
8.

Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach.

Marquand AF, O'Daly OG, De Simoni S, Alsop DC, Maguire RP, Williams SC, Zelaya FO, Mehta MA.

Neuroimage. 2012 Apr 2;60(2):1015-24. doi: 10.1016/j.neuroimage.2012.01.058. Epub 2012 Jan 14.

9.

Methylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorder.

An L, Cao XH, Cao QJ, Sun L, Yang L, Zou QH, Katya R, Zang YF, Wang YF.

Neuropsychopharmacology. 2013 Jun;38(7):1287-95. doi: 10.1038/npp.2013.27. Epub 2013 Jan 22.

10.

The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder.

Szobot CM, Ketzer C, Cunha RD, Parente MA, Langleben DD, Acton PD, Kapczinski F, Rohde LA.

Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):423-6. Epub 2003 Jan 11.

PMID:
12634972
11.

Effects of long-term methylphenidate treatment: a pilot follow-up clinical and SPECT study.

Akay AP, Kaya GC, Emiroğlu NI, Aydin A, Monkul ES, Taşçi C, Miral S, Durak H.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1219-24. Epub 2006 Apr 17.

PMID:
16616981
12.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
13.

Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.

Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J.

Eur Neuropsychopharmacol. 2013 Dec;23(12):1714-23. doi: 10.1016/j.euroneuro.2013.05.002. Epub 2013 May 31.

PMID:
23731497
14.

Mechanism of action of methylphenidate: insights from PET imaging studies.

Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ.

J Atten Disord. 2002;6 Suppl 1:S31-43.

PMID:
12685517
15.

Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment.

Matochik JA, Liebenauer LL, King AC, Szymanski HV, Cohen RM, Zametkin AJ.

Am J Psychiatry. 1994 May;151(5):658-64.

PMID:
8166305
16.

Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study.

Rohde LA, Roman T, Szobot C, Cunha RD, Hutz MH, Biederman J.

Synapse. 2003 May;48(2):87-9.

PMID:
12619042
17.

Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.

Park MH, Kim JW, Yang YH, Hong SB, Park S, Kang H, Kim BN, Shin MS, Yoo HJ, Cho SC.

Neurosci Lett. 2012 Apr 18;514(2):159-63. doi: 10.1016/j.neulet.2012.02.079. Epub 2012 Mar 3.

PMID:
22405810
18.

Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review.

Czerniak SM, Sikoglu EM, King JA, Kennedy DN, Mick E, Frazier J, Moore CM.

Harv Rev Psychiatry. 2013 May-Jun;21(3):151-62. doi: 10.1097/HRP.0b013e318293749e. Review.

19.

Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.

Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E.

Neuropharmacology. 2009 Dec;57(7-8):640-52. doi: 10.1016/j.neuropharm.2009.08.013. Epub 2009 Aug 26.

PMID:
19715709
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk